SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001479290-22-000102
Filing Date
2022-11-08
Accepted
2022-11-08 16:32:30
Documents
80
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rvnc-20220930.htm   iXBRL 10-Q 2296008
2 EX-10.1 rvncq322exhibit101.htm EX-10.1 23127
3 EX-31.1 rvncq322exhibit311.htm EX-31.1 8776
4 EX-31.2 rvncq322exhibit312.htm EX-31.2 8788
5 EX-32.1 rvncq322exhibit321.htm EX-32.1 6491
6 EX-32.2 rvncq322exhibit322.htm EX-32.2 6543
  Complete submission text file 0001479290-22-000102.txt   9512772

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvnc-20220930.xsd EX-101.SCH 56608
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvnc-20220930_cal.xml EX-101.CAL 109457
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvnc-20220930_def.xml EX-101.DEF 270139
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvnc-20220930_lab.xml EX-101.LAB 682136
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvnc-20220930_pre.xml EX-101.PRE 447360
74 EXTRACTED XBRL INSTANCE DOCUMENT rvnc-20220930_htm.xml XML 1781941
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36297 | Film No.: 221369420
SIC: 2834 Pharmaceutical Preparations